FAU own research funding: EFI / IZKF / EAM ...
Start date : 01.10.2019
End date : 30.09.2020
18F-FDG PET/CT is as promising tool for determining treatment response in Ewing Sarcoma (EwS). Standardized uptake values as marker for metabolic tumor activity can be determined in serial scans to determine response to therapy. EwS is characetrised by circulating tumor DNA (ctDNA) that can be quantified from patients' plasma. We intend to use 18F-FDG-PET/CT and ctDNA to determine treatment response in 20 children and adolescents suffering from EwS.